Citigroup’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $13.2K | Buy |
|
|||||
|
2023
Q3 | $2.44K | Sell |
|
|||||
|
2023
Q2 | $4.66K | Buy |
|
|||||
|
2023
Q1 | $1.41K | Sell |
|
|||||
|
2022
Q4 | $1.77K | Buy |
|
|||||
|
2022
Q3 | $2K | Sell |
|
|||||
|
2022
Q2 | $17K | Sell |
|
|||||
|
2022
Q1 | $8K | Sell |
|
|||||
|
2021
Q4 | $39K | Buy |
|
|||||
|
2021
Q3 | $14K | Sell |
|
|||||
|
2021
Q2 | $29K | Buy |
|
|||||
|
2021
Q1 | $15K | Buy |
|